Skip to main content
. Author manuscript; available in PMC: 2021 Dec 10.
Published in final edited form as: Clin Cancer Res. 2020 Jan 14;26(9):2104–2110. doi: 10.1158/1078-0432.CCR-19-2591

Table 1.

Baseline characteristics of patients in initial and randomized cohorts.

Variable Randomized (2:1)
Radium + Enza (n=8) Radium + Enza (n=27) Enza (n=14)
Age (years), Median (Range) 77 (58 – 88) 70 (56 – 84) 71 (55 – 82)
PSA (ng/mL) , Median (Range) 72.4 (15.9 – 501.5) 18.9 (3.4 – 144.7) 26.6 (4 – 261.3)
Alkaline Phosphatase (U/L) , Median (Range) 98 (53 – 394) 81 (29 – 254) 96 (44 – 202)
Hemoglobin (g/dL) , Median (Range) 12.7 (10.3 – 15.8) 14.2 (11.5 – 19) 13.4 (10.6 – 15.3)
Albumin (g/dL) , Median (Range) 3.9 (3.6 – 4.3) 4.1 (3.5 – 4.5) 4.1 (3.7 – 4.4)
ECOG 0, n (%) 2 (25%) 15 (56%) 7 (50%)
ECOG 1, n (%) 6 (75%) 12 (44%) 7 (50%)